InsidersTradesSigma
Browse the complete record of transactions filed by Warner Brent, Président, Thérapie Génique. Director active across 1 companies, notably Poseida Therapeutics, Inc.. Cumulatively, 1 disclosures have been published. The latest transaction was disclosed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
1 of 1 declaration
Brent Warner is the President of Gene Therapy at Poseida Therapeutics, Inc. He leads the company's operations and strategy in the field of gene therapies. Poseida Therapeutics is a biopharmaceutical company specializing in developing innovative treatments. Warner's experience in the biopharmaceutical sector is essential for the company's success.